Vaccination against feline pneumonitis.
A commercially available modified live chlamydial vaccine against feline pneumonitis was tested in 26 cats for its ability to protect against aerosol challenge exposure to the feline pneumonitis strain of Chlamydia psittaci. After cats were challenge exposed (30 days after vaccination), pyrexia of greater than 40.0 C occurred in 81% of nonvaccinated (control) cats and in 13% of vaccinated cats (principals). Evidence of upper respiratory tract disease and the presence of the agent in ocular fluids were observed less frequently in principals than in nonvaccinated cats. In the cats euthanatized at intervals of 3 days after challenge exposure, C psittaci was demonstrated in 60% of tissues tested from nonvaccinated controls and in 34% of similar tissues obtained from principals.
D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis; D002371:Cat Diseases / Q000382:microbiology / Q000517:prevention & control*; D002415:Cats; D002689:Chlamydia / Q000276:immunology / Q000302:isolation & purification; D002690:Chlamydia Infections / Q000382:microbiology / Q000517:prevention & control / Q000662:veterinary*; D003231:Conjunctivitis / Q000662:veterinary; D012220:Rhinitis / Q000662:veterinary; D014611:Vaccination / Q000662:veterinary*
D000907:Antibodies, Bacterial